Aasim Sheikh Selected Research

Aasim Sheikh Research Topics

Disease

9	Fibrosis (Cirrhosis) 01/2022 - 05/2015
3	Alcoholic Fatty Liver 01/2022 - 01/2020
3	Non-alcoholic Fatty Liver Disease 07/2021 - 01/2020
3	Inflammation (Inflammations) 01/2021 - 01/2020
3	Infections 11/2016 - 05/2015
2	Pruritus (Itching) 07/2021 - 01/2021
2	Chronic Hepatitis C 01/2016 - 05/2015
1	Pain (Aches) 12/2023
1	Chronic Pancreatitis 12/2023
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2022
1	Fatigue 07/2021
1	Cicatrix (Scar) 01/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020
1	Fatty Liver 01/2020

Drug/Important Bio-Agent (IBA)

3	selonsertibIBA 07/2021 - 01/2020
3	Ribavirin (Virazole)FDA LinkGeneric 11/2016 - 05/2015
3	Protease Inhibitors (Protease Inhibitor)IBA 11/2016 - 05/2015
2	nasIBA 07/2021 - 01/2021
2	firsocostatIBA 07/2021 - 01/2021
2	cilofexorIBA 07/2021 - 01/2021
2	Drug CombinationsIBA 07/2021 - 01/2021
2	Alanine Transaminase (SGPT)IBA 01/2021 - 01/2020
2	Bile Acids and Salts (Bile Acids)IBA 01/2021 - 01/2020
2	NucleotidesIBA 11/2016 - 01/2016
2	SofosbuvirIBA 11/2016 - 01/2016
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 12/2023
1	camostatIBA 12/2023
1	saroglitazarIBA 01/2022
1	EDP-305IBA 01/2022
1	Alkaline PhosphataseIBA 01/2022
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2022
1	Investigational DrugsIBA 07/2021
1	Keratin-18 (Keratin 18)IBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	CollagenIBA 01/2021
1	BilirubinIBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	EnzymesIBA 01/2020
1	3- (2- (2- tert- butylphenylaminooxalyl)aminopropionylamino)- 4- oxo- 5- (2,3,5,6- tetrafluorophenoxy)pentanoic acidIBA 01/2020
1	sodium-bile acid cotransporterIBA 01/2020
1	volixibatIBA 01/2020
1	CaspasesIBA 01/2020
1	MAP Kinase Kinase Kinase 5IBA 01/2020
1	velpatasvirIBA 11/2016
1	voxilaprevirIBA 11/2016
1	SimeprevirIBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 05/2015
1	asunaprevirIBA 05/2015
1	daclatasvirIBA 05/2015
1	InterferonsIBA 05/2015
1	8- cyclohexyl- N- ((dimethylamino)sulfonyl)- 1,1a,2,12b- tetrahydro- 11- methoxy- 1a- ((3- methyl- 3,8- diazabicyclo(3.2.1)oct- 8- yl)carbonyl)cycloprop(d)indolo(2,1- a)(2)benzazepine- 5- carboxamideIBA 05/2015

Therapy/Procedure

3	Therapeutics 12/2023 - 05/2015